SCHEMBL22876944

SCHEMBL22876944

CCC(C)c1ccc2c(n1)CCN(C(=O)CN1CCC1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.38
CDK4 P11802 3/20 0.38
CDK2 P24941 3/20 0.38
CDK6 Q00534 3/20 0.38
CDK1 P06493 2/20 0.38
CDK7 P50613 2/20 0.38
CDK9 P50750 2/20 0.38
CCNB1 P14635 1/20 0.38
CCNE1 P24864 1/20 0.38
NPC1 O15118 1/20 0.38
HPGDS O60760 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
PARP1 P09874 2/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414456 0.92 CDK1 (0.44) KDRCDK4CDK2CDK6CDK1
SCHEMBL20203582 0.90 KDR (0.40) KDRCDK4CDK2CDK6CDK1
SCHEMBL22877016 0.89 CDK1 (0.39) KDRCDK4CDK2CDK6CDK1
SCHEMBL21414388 0.88 KDR (0.41) KDRCDK4CDK2CDK6CDK1
SCHEMBL23733468 0.87 NPC1 (0.42) KDRCDK4CDK2CDK6CDK1
SCHEMBL21414426 0.85 TLR9 (0.38) KDRCDK4CDK2CDK6CDK1
SCHEMBL20203603 0.82 CDK1 (0.46) KDRCDK4CDK2CDK6CDK1
SCHEMBL21414440 0.81 KDR (0.42) KDRCDK4CDK2CDK6CDK1
SCHEMBL20203642 0.80 CDK4 (0.47) KDRCDK4CDK2CDK6CDK1
SCHEMBL20203605 0.79 KDM4E (0.43) KDRCDK4CDK2CDK6CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 EP disclosed